How to Use a TENS Machine for Overactive Bladder

Using a TENS machine for overactive bladder involves placing electrode pads near specific nerves, typically around the ankle or lower back, and running low-level electrical pulses for about 20 to 30 minutes per session. The electrical stimulation works by interrupting the nerve signals that cause the bladder muscle to contract when it shouldn’t, and clinical trials show it can reduce urgency, frequency, and incontinence episodes. The approach is straightforward enough to do at home, but where you stick the pads, what settings you dial in, and how often you repeat sessions all matter for results.

Where to Place the Electrodes

The two most studied electrode placements for overactive bladder are the posterior tibial nerve area (near the ankle) and the parasacral region (lower back). These are not interchangeable in theory, but research suggests they produce comparable improvements in urgency.

For tibial nerve stimulation, one electrode goes just above the inner ankle bone (the medial malleolus), roughly three finger-widths up, while the second pad typically goes on the sole of the foot or slightly below the ankle on the same side. This targets the posterior tibial nerve, which shares a spinal root with the nerves that control the bladder. A study protocol comparing tibial placement with parasacral placement noted that if the two approaches reduce urgency equally, the parasacral option could serve populations who cannot use the ankle site, such as people with lower-limb amputations or severe sensory loss in the legs.¹

For parasacral placement, the pads go on the lower back over the S2–S3 dermatomes, roughly at the level of the sacral dimples. This approach targets the sacral nerve roots more directly. Several pediatric trials have used parasacral placement with good results, and it is the more common choice in studies involving children.

If you are working from a home TENS unit without clinical guidance, the tibial nerve location tends to be easier to find on your own. You should feel a tingling or mild pulsing sensation radiating toward the sole of the foot or toes when the electrode is positioned correctly and the intensity is adequate.

Settings That Clinical Trials Actually Use

There is no single universally agreed-upon protocol. One review noted bluntly that the optimal stimulation parameters for bladder dysfunction remain unclear.² That said, most clinical trials cluster around a fairly narrow range of settings, and those settings are a reasonable starting point.

Frequency is typically set between 10 and 20 Hz. A trial in people with neurogenic overactive bladder used 20 Hz with a pulse width of 150 microseconds, applied for 30 minutes once daily over 90 days.³ A pediatric trial used 10 Hz for 20-minute sessions, three times weekly.⁴ A study characterizing nerve recruitment in healthy adults used 20 Hz with a 200-microsecond pulse width and found that participants could comfortably tolerate stimulation at about twice the threshold needed to activate the target nerve.⁵

In practical terms, here is what to dial in on a home TENS unit:

Frequency: 10–20 Hz (lower than the 80–120 Hz range often used for pain relief)
Pulse width: 150–200 microseconds
Intensity: Turn it up until you feel a clear but comfortable tingling or pulsing, well below the point of pain or visible muscle contraction
Session length: 20–30 minutes

The intensity question is worth lingering on. You want the stimulation strong enough that you feel it clearly, which suggests the nerve fibers are being activated, but not so strong that it causes discomfort or cramping. If you feel your toes curling involuntarily or muscles twitching hard, dial it back. The goal is sensory-level stimulation, not motor-level.

How Often and How Long

Session frequency in the research ranges from once a week to daily, with most protocols landing on two to three sessions per week or daily use. A multi-arm randomized trial tested several schedules and found that even once-weekly sessions applied to one leg significantly reduced urgency and incontinence episodes compared to placebo.⁶ Twice-weekly sessions in that same trial showed an edge in reducing overall urinary frequency.

In pediatric studies, a comparison of two versus three weekly parasacral sessions found no significant difference in outcomes: about half the children in the twice-weekly group and roughly 60% in the three-times-weekly group had complete resolution of symptoms.⁷ This is reassuring if your schedule makes daily or near-daily sessions impractical.

Treatment courses in most trials last 8 to 12 weeks before outcomes are assessed. Some protocols extend to 90 days of daily use. The evidence so far does not suggest a single “correct” schedule, but it does suggest that consistency matters more than cramming in extra sessions. If you can manage three 20-minute sessions a week for 12 weeks, you are broadly in line with what most trials have tested.

What the Evidence Says About Effectiveness

TENS consistently outperforms sham treatment in controlled trials, though the margins vary. One trial found significant improvement in overactive bladder symptom scores among TENS-treated patients, with two patients becoming completely dry.⁸ A study of 42 adults with refractory overactive bladder that had not responded to other treatments found that half responded successfully after 12 weeks of TENS, with average daily voids dropping from 15 to 11 and average voided volume increasing from 160 to 230 mL. The positive effects held over a mean follow-up of 21 months in most responders.⁹

A pooled analysis of eight randomized controlled trials in children found that TENS led to greater decreases in wet days per week, daily voiding frequency, and daily incontinence episodes compared to controls. Importantly, the analysis also showed TENS did not increase pain or discomfort scores, confirming that the treatment is well tolerated even in younger patients.¹⁰

One caution: the placebo effect in bladder trials is real and sometimes substantial. In one controlled trial, urinary frequency improved in both the active treatment group and the sham group, and the difference between them did not reach statistical significance.¹¹ The expectation of receiving treatment, the structured routine of regular sessions, and the act of paying attention to bladder habits may all contribute to improvements that are not purely electrical. That does not mean TENS does not work beyond placebo, but it is worth keeping expectations realistic: the effect is genuine but moderate, and it works better for some people than others.

How TENS Compares to Medications

The standard first-line drugs for overactive bladder are anticholinergics like oxybutynin and newer medications like solifenacin. They work, but side effects are a persistent problem: dry mouth, constipation, blurred vision, and cognitive effects in older adults drive many people to quit.

A meta-analysis comparing TENS to oxybutynin in children found TENS was roughly twice as likely to improve symptoms, while causing far fewer side effects.¹² In adults, a trial comparing transcutaneous tibial nerve stimulation to solifenacin found that both treatments significantly improved symptoms and quality of life. The TENS group showed slightly greater improvement in symptom severity and incontinence, and crucially, no patients in the TENS group reported side effects, compared to nearly nine out of ten solifenacin users.¹³

This does not mean you should toss your medication. Some trials have tested TENS as an add-on to drugs and pelvic floor exercises rather than a replacement. A large trial of 315 patients used TENS alongside anticholinergics and pelvic floor training for 12 weeks.¹⁴ The combination approach is reasonable, especially if you are already on medication and want to add something non-drug to the mix.

TENS Versus Needle-Based Tibial Nerve Stimulation

You may have heard of percutaneous tibial nerve stimulation (PTNS), which involves inserting a thin needle near the ankle and running a current through it. PTNS has a longer track record in clinical guidelines, and it requires weekly in-office visits. A natural question is whether the surface-electrode version works just as well.

A meta-analysis directly comparing transcutaneous and percutaneous tibial nerve stimulation found no significant difference in voiding frequency, urgency episodes, incontinence episodes, nocturia, or quality-of-life scores.¹⁵ The practical advantage of the surface version is obvious: you can do it at home without needles, without weekly clinic visits, and without co-pays for each session. For people who respond to tibial nerve stimulation, the transcutaneous route appears to be a legitimate alternative to the percutaneous one.

Doing It at Home

One of the biggest selling points of TENS is that you do not need a clinician hovering over you for every session. Home-based use has been tested directly, and compliance tends to be high. A feasibility study of home-based tibial nerve stimulation found that patients assigned to daily treatment completed about 90% of their sessions, while those assigned to weekly sessions hit 100%. Five participants found the stimulation uncomfortable and dropped out, and one developed mild skin redness from the adhesive pads, but no serious safety issues arose over the 12-week course.¹⁶

A separate pediatric study of at-home parasacral TENS reported a median session completion rate of 98%.¹⁷ Another trial with children found excellent compliance across all groups, no adverse effects, and high willingness to use the therapy again.¹⁸

A few practical tips if you are using a standard consumer TENS unit at home:

Check your unit’s range: Many pain-focused TENS machines default to frequencies above 50 Hz. You need one that lets you dial down to 10–20 Hz and adjust the pulse width to at least 150 microseconds.
Electrode quality matters: Gel pads lose stickiness over time, which reduces the quality of the electrical contact and can cause uneven stimulation or skin irritation. Replace pads when they stop adhering firmly.
Stay consistent: Missing occasional sessions is not a crisis, but skipping weeks at a time likely undermines results. Treat it like any other therapy that depends on cumulative exposure.
Note your symptoms: Keeping a simple bladder diary, even just counting how many times you urinate per day and how many urgency or leakage episodes you have, gives you an objective way to tell whether the treatment is working after 8 to 12 weeks.

When the Cause Is Neurological

Overactive bladder caused by neurological conditions like spinal cord injury, multiple sclerosis, or stroke is a somewhat different beast from the idiopathic kind. The underlying mechanism involves disrupted nerve pathways rather than an overly sensitive bladder muscle acting on its own. TENS has been studied in this population specifically.

A meta-analysis of randomized trials in people with spinal cord injury found that TENS significantly increased maximum bladder capacity in the acute phase after injury and was not associated with major adverse events.¹⁹ A later meta-analysis confirmed that adding TENS to conventional treatment resulted in both larger bladder capacity and lower residual urine volume compared to conventional treatment alone.²⁰

A trial in patients with neurogenic overactive bladder found that TENS significantly improved voiding diary parameters and overactive bladder symptom scores, as well as several domains of general health-related quality of life.³ If your overactive bladder stems from a neurological condition, the evidence supports trying TENS, though you should coordinate with whoever manages your neurological care since the underlying condition adds complexity.

TENS for Children

Overactive bladder is common in children, and the limited side-effect profile of TENS makes it especially appealing for younger patients. The research in children is actually stronger and more consistent than much of the adult literature, partly because pediatric urologists have studied it more systematically.

The pooled analysis of eight randomized controlled trials mentioned earlier showed clear benefits in terms of reduced wet days, voiding frequency, and incontinence episodes, with no increase in discomfort.¹⁰ The meta-analysis comparing TENS to oxybutynin found TENS was not only more effective but caused dramatically fewer side effects in children.¹²

One nuance in the pediatric literature is that while TENS consistently improves urinary symptoms, its impact on broader quality of life and psychological well-being is less clear. A multicenter study found that parasacral TENS improved urinary symptoms and quality of life scores, but psychological symptoms as measured by a separate assessment did not change.²¹ Another study found improvements in urinary symptom scores but no statistically significant change in overall quality-of-life or psychological measures.²² This suggests that while the bladder symptoms get better, the emotional burden of living with OAB may need to be addressed separately.

How the Mechanism Works

The basic idea is rooted in something called the gate control theory. Nerves that carry sensation from the skin travel along the same spinal pathways as the nerves that control the bladder. When you electrically stimulate those sensory nerves at the right frequency, the signals compete with and effectively dampen the overactive bladder reflex at the spinal cord level.²³ Think of it as creating enough “noise” on the nerve highway that the erroneous urgency signals get drowned out before they reach the point of triggering a bladder contraction.

This is also why electrode placement matters. The posterior tibial nerve and the sacral nerves share spinal segments with the bladder’s nerve supply. Stimulating a random spot on your thigh or arm would not produce the same effect because those nerves do not converge on the same spinal circuitry. The specificity of placement is not about proximity to the bladder; it is about which nerves share a spinal neighborhood with the bladder’s control system.

What Different Schedules and Protocols Produce

The multi-arm trial that tested several TENS protocols against placebo offers some of the clearest data on how scheduling choices affect outcomes. Using one leg once a week reduced urgency and incontinence episodes compared to placebo. The twice-weekly one-leg protocol beat both the two-legs-once-weekly protocol and placebo for overall urinary frequency. And for nocturia specifically, the two-legs-once-weekly approach performed better than the one-leg-twice-weekly schedule and placebo.⁶

This pattern suggests the relationship between treatment frequency, electrode configuration, and which symptom improves most is not perfectly straightforward. If your biggest issue is nighttime waking, a different protocol might serve you better than if your primary complaint is daytime urgency. These are the kinds of details worth discussing with a clinician if you have access to one, since most over-the-counter TENS instructions are designed for pain management and do not address bladder-specific protocols at all.

For the long haul, the study of refractory overactive bladder patients provides some encouragement. Among the half who responded to 12 weeks of TENS, most maintained their improvements over an average follow-up of nearly two years.⁹ Whether those patients continued periodic maintenance sessions or stopped entirely is worth asking about, since most experts expect that some ongoing stimulation is needed to preserve the benefits. TENS does not “fix” the underlying bladder sensitivity permanently; it manages it, more like exercise for blood pressure than surgery for a broken bone.